Moderna | MRNA - Ebitda



Moderna reported $-760000000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Acadia Pharmaceuticals USD 35.31M 13.07M Jun/2025
Agios Pharmaceuticals USD -125797000 20.45M Jun/2025
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Arrowhead Research USD -159327000 556.67M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Celltrion KRW 221.03B 57.43B Mar/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Kangmei Pharma -3262057.35 15.91M Sep/2024
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1100000 200K Dec/2024
Moderna USD -760000000 164M Jun/2025
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Pharma Mar EUR 26.15M 27.2M Jun/2025
Qiagen NV USD 208.98M 38.23M Jun/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Sartorius EUR 264.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD -101000 2.32M Nov/2024
Ultragenyx Pharmaceutical USD -91344000 35.09M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M Mar/2025